Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
Mol Ther Methods Clin Dev
.
2022 Mar 9:25:41-42.
doi: 10.1016/j.omtm.2022.02.003.
eCollection 2022 Jun 9.
Authors
Ario de Marco
1
,
Lucio Barile
2
Affiliations
1
Laboratory for Environmental and Life Sciences, University of Nova Gorica, Nova Gorica, Slovenia.
2
Laboratory for Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale and Faculty of Biomedical Sciences, Università Svizzera italiana, Lugano, Switzerland.
PMID:
35317050
PMCID:
PMC8917268
DOI:
10.1016/j.omtm.2022.02.003
No abstract available
Publication types
Editorial